Influence of the proton pump inhibitor esomeprazole on the bioavailability of regorafenib

2018-10-01

Annals of Oncology , Volume 29 p. viii158

Additional Metadata
Persistent URL	doi.org/10.1093/annonc/mdy281.021, hdl.handle.net/1765/125529
Journal	Annals of Oncology
Organisation	Erasmus MC Cancer Institute
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Man, F., Hussaarts, K., de With, M. (M.), Oomen - de Hoop, E., van Halteren, H., van der Burg-De Graauw, N.C.H.P. (N. C.H.P.), Eskens, F., van Gelder, T., van Leeuwen, R.& Mathijssen, R. (2018). Influence of the proton pump inhibitor esomeprazole on the bioavailability of regorafenib. Annals of Oncology, 29.https://doi.org/10.1093/annonc/mdy281.021

Publication